Drugs / Berberine
last change Aug 2026 re-read 2 minutes ago

Berberine

Traditional medicine (herbal / TCM) targets KCNH6, LDLR via inhibition

Developed for
Helicobacter pylori infectious disease · metabolic syndrome X · schizophrenia · type 2 diabetes mellitus · colorectal adenoma · hyperlipidemia · coronary artery disorder · diabetes mellitus
+22 more · dyspepsia · prediabetes syndrome · abdominal obesity-metabolic syndrome · gastritis · hypertensive disorder · NAFLD1 · obesity disorder · peptic ulcer disease · polycystic ovary syndrome · atherosclerotic cardiovascular disease · chronic endometritis · COVID-19 · diverticulitis · end stage renal failure · esophageal varices · gastric intestinal metaplasia · hyperglycemia · hyperlipidemia, combined, 2 · latent autoimmune diabetes in adults · lung adenocarcinoma · metabolic dysfunction-associated steatohepatitis · ulcerative colitis
Investigated by
Xijing Hospital of Digestive Diseases · Shanghai Jiao Tong University School of Medicine · Tianjin Anding Hospital · Xijing Hospital · China National Center for Cardiovascular Diseases · Heilongjiang University of Chinese Medicine
+53 more · Ministry of Science and Technology of the People´s Republic of China · Nanjing First Hospital, Nanjing Medical University · Peking Union Medical College Hospital · The University of Hong Kong · Beijing Tongren Hospital · Cardiomed LLC, Armenia · Center for New Medical Technologies, Novosibirsk, Russia · Chang'An Hospital · Chinese Medical Association · Chinese Society of Cardiology · Dr. Adi Lahat · EuroPharma, Inc. · Food and Health Bureau, Hong Kong · Fudan University · Fujian Cancer Hospital · Genertec Universal Xi'an Aero-Engine hospital (Xi' an) Co., Ltd · Guangdong Provincial Hospital of Traditional Chinese Medicine · Guangdong Provincial People's Hospital · Hospital Civil de Guadalajara · Institute of Fine Organic Chemistry of the National Academy of Science, Armenia · Jin-Kui Yang · Jing-yuan Fang, MD, Ph. D · Jun Tao · National Cancer Institute (NCI) · National Institutes of Health (NIH) · Peking University People's Hospital · Phytomed AB, Sweden · S.LAB (SOLOWAYS) · Scientific Center of Drug and Medical Technologies Expertise of the Ministry of Health, Armenia · Second Affiliated Hospital of Xi'an Jiaotong University · Second Xiangya Hospital of Central South University · Shaanxi Aerospace Hospital · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai Jiao Tong University Affiliated Sixth People's Hospital · Shanghai Mental Health Center · Shanghai Municipal Science and Technology Commission · Shangluo Central Hospital · Tang Yida · The Affiliated Hospital of Hangzhou Normal University · The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Tianjin Second People's Hospital · Tianjin Third Central Hospital · University of Guadalajara · University of Roma La Sapienza · Wenzhou Medical University · Xi'an Central Hospital · Xi'an Gaoxin Hospital · Xin Gao · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Xinjiang Medical University · Yan'an People's Hospital · Yan'an University Affiliated Hospital · Yu Chen

Trials 57 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT05947370 Oct 2022 → Apr 2023 diabetes mellitus Beijing Tongren Hospital Completed No outcome recorded
Phase 0 NCT03972215 Oct 2019 → Jan 2020 diabetes mellitus Jin-Kui Yang Completed No outcome recorded
Phase 12 trials
Phase 1 NCT04918667 Sep 2024 → Nov 2025 overdue EuroPharma, Inc. Not yet recruiting No outcome recorded
Phase 1 NCT02365480 Jun 2016 → Feb 2018 ulcerative colitis National Cancer Institute (NCI) Completed No outcome recorded
Phase 1/24 trials
Phase 1/2 NCT07180563 Mar 2025 → Nov 2026 expected chronic endometritis The Fourth Affiliated Hospital of Zhejiang University School of Medicine Recruiting No outcome recorded
Phase 1/2 NCT04434365 Jun → Nov 2019 coronary artery disorder Peking Union Medical College Hospital Unknown No outcome recorded
Phase 1/2 NCT02194946 Jul 2014 → Dec 2020 end stage renal failure Guangdong Provincial Hospital of Traditional Chinese Medicine Unknown No outcome recorded
Phase 1/2 NCT00425009 Jan → Dec 2004 type 2 diabetes mellitus Shanghai Jiao Tong University School of Medicine Completed No outcome recorded
Phase 24 trials
Phase 2 NCT05596214 Aug 2022 → Sep 2024 diverticulitis Dr. Adi Lahat Unknown No outcome recorded
Phase 2 NCT03486496 Jun 2018 → Jun 2019 lung adenocarcinoma Fujian Cancer Hospital Unknown No outcome recorded
Phase 2 NCT03909763 Jan 2016 → Dec 2020 Peking University People's Hospital Unknown No outcome recorded
Phase 2 NCT00633282 Mar 2008 → Aug 2011 NAFLD1 Xin Gao Completed No outcome recorded
Phase 2/37 trials
Phase 2/3 NCT06782646 Aug 2024 → Dec 2025 overdue hyperlipidemia The University of Hong Kong Enrolling by invitation No outcome recorded
Phase 2/3 NCT03770325 Apr 2019 → Nov 2020 The University of Hong Kong Completed No outcome recorded
Phase 2/3 NCT03333265 Sep 2017 → Aug 2020 colorectal adenoma Xijing Hospital of Digestive Diseases Completed No outcome recorded
Phase 2/3 NCT03281096 Aug 2017 → Oct 2020 colorectal adenoma Xijing Hospital of Digestive Diseases Completed No outcome recorded
Phase 2/3 NCT02082756 Nov 2015 → Apr 2018 prediabetes syndrome Xijing Hospital Withdrawn No outcome recorded
Phase 2/3 NCT02084004 Nov 2015 → Apr 2018 type 2 diabetes mellitus Xijing Hospital Withdrawn No outcome recorded
Phase 2/3 NCT02226185 Nov 2014 → Dec 2018 colorectal adenoma Shanghai Jiao Tong University School of Medicine Completed No outcome recorded
Phase 35 trials
Phase 3 NCT04543643 Nov 2021 → Oct 2023 esophageal varices, hepatitis C induced liver cirrhosis Tianjin Second People's Hospital Unknown No outcome recorded
Phase 3 NCT04860063 Apr 2021 → Apr 2022 HIV infectious disease, glucose intolerance, hyperlipidemia, lipodystrophy +1 Hospital Civil de Guadalajara Unknown No outcome recorded
Phase 3 NCT02861261 Aug 2016 → Dec 2017 type 2 diabetes mellitus Shanghai Jiao Tong University School of Medicine Unknown No outcome recorded
Phase 3 NCT02548832 Apr 2013 → Apr 2020 hyperlipidemia, combined, 2 University of Guadalajara Completed No outcome recorded
Phase 3 NCT00462046 Apr 2005 → Sep 2006 metabolic syndrome X, type 2 diabetes mellitus Shanghai Jiao Tong University School of Medicine Completed No outcome recorded
Phase 422 trials
Phase 4 NCT07129460 Oct 2025 → Dec 2026 expected gastric intestinal metaplasia Xijing Hospital of Digestive Diseases Not yet recruiting No outcome recorded
Phase 4 NCT07306988 Apr 2025 → Jun 2026 overdue Helicobacter pylori infectious disease, metabolic syndrome X Nanjing First Hospital, Nanjing Medical University Recruiting No outcome recorded
Phase 4 NCT06514274 Sep 2024 → Apr 2025 Helicobacter pylori infectious disease, chronic gastritis Xijing Hospital of Digestive Diseases Completed No outcome recorded
Phase 4 NCT06603688 Nov 2023 → Nov 2024 Helicobacter pylori infectious disease, chronic gastritis Xijing Hospital of Digestive Diseases Unknown No outcome recorded
Phase 4 NCT05749874 Oct 2023 → Dec 2026 expected abdominal obesity-metabolic syndrome, atherosclerotic cardiovascular disease, hyperlipidemia, hypertensive disorder +1 China National Center for Cardiovascular Diseases Active not recruiting No outcome recorded
Phase 4 NCT05647915 Jul 2023 → Aug 2024 NAFLD1, abdominal obesity-metabolic syndrome, obesity disorder China National Center for Cardiovascular Diseases Completed No outcome recorded
Phase 4 NCT04698330 May 2022 → Dec 2025 overdue latent autoimmune diabetes in adults Second Xiangya Hospital of Central South University Not yet recruiting No outcome recorded
Phase 4 NCT03708549 Dec 2021 → Oct 2023 metabolic syndrome X, schizophrenia Tianjin Anding Hospital Unknown No outcome recorded
Phase 4 NCT05014334 Dec 2021 → Mar 2022 Helicobacter pylori infectious disease, chronic gastritis Xijing Hospital of Digestive Diseases Completed No outcome recorded
Phase 4 NCT05105321 Dec 2021 → Dec 2026 expected metabolic syndrome X Tang Yida Not yet recruiting No outcome recorded
Phase not applicable11 trials
NCT07519681 May → Sep 2026 expected colorectal adenoma, colorectal cancer Jing-yuan Fang, MD, Ph. D Not yet recruiting No outcome recorded
NCT06911983 Jul → Dec 2025 overdue type 2 diabetes mellitus S.LAB (SOLOWAYS) Not yet recruiting No outcome recorded
NCT05720299 Mar → Jun 2025 prediabetes syndrome Yu Chen Completed No outcome recorded
NCT07356765 Sep 2023 → Jan 2026 overdue schizophrenia Tianjin Anding Hospital Enrolling by invitation No outcome recorded
NCT07359209 Jul 2023 → Jan 2026 Tianjin Anding Hospital Completed No outcome recorded
NCT03330184 Oct 2015 → Apr 2018 Xijing Hospital Completed No outcome recorded
NCT03251716 Jan 2015 → Oct 2017 metabolic syndrome X, schizophrenia Tianjin Anding Hospital Completed No outcome recorded
NCT03548155 Jul 2014 → Dec 2015 schizophrenia Tianjin Anding Hospital Completed No outcome recorded
NCT02936414 Jul 2014 → Aug 2015 schizophrenia Tianjin Anding Hospital Completed No outcome recorded
NCT01138930 Jun 2010 → Jun 2013 obesity disorder, polycystic ovary syndrome Heilongjiang University of Chinese Medicine Unknown No outcome recorded
Also used as a comparator or background therapy in 4 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/31 trial
Phase 2/3 NCT02983188 Comparator Apr 2018 → Dec 2020 metabolic syndrome X, schizophrenia The University of Hong Kong Completed No outcome recorded
Phase 43 trials
Phase 4 NCT02962245 Comparator Nov 2016 → Jan 2018 ulcerative colitis Xijing Hospital of Digestive Diseases Withdrawn No outcome recorded
Phase 4 NCT01649986 Comparator Jan 2014 → Dec 2015 hyperlipidemia University of Roma La Sapienza Unknown No outcome recorded
Phase 4 NCT02001883 Comparator Nov 2013 → Dec 2014 coronary artery disorder University of Roma La Sapienza Unknown No outcome recorded

Evidence & citations 28 cited values

Every value below carries the sentence it was read from. 67 sources stand behind the page.

FieldValueCited text
Known as Berberine Berberine * Dose: 500 mg three times daily (1,500 mg/day total) * Formulation: standardized berberine HCl tablets * Duration: 12 weeks” NCT06911983
54

“nutraceutical combined pill (1 capsule/day containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg).” NCT02001883

“os, 1 pill containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg, once daily, 1 year” NCT01490229

“1 capsule/day containing red yeast rice 200 mg, policosanol 10 mg, and berberine 500 mg” NCT01649986

“oral administration of berberine hydrochloride tablets 100mg Tid per day” NCT07180563

NCT03708549

NCT07306988

NCT00633282

NCT02633930

NCT01138930

NCT03770325

NCT05947370

NCT06603688

NCT04697186

NCT00425009

NCT03609892

NCT02808351

NCT02806999

NCT04543643

NCT03330184

NCT03548155

NCT07129460

NCT01697735

NCT02296021

NCT03486496

NCT02084004

NCT03251716

NCT01116167

NCT06514274

NCT02962245

NCT03909763

NCT02936414

NCT05105321

NCT03972215

NCT05720299

NCT00462046

NCT07356765

NCT04860063

NCT04918667

NCT02983188

NCT03198572

NCT02226185

NCT05749874

NCT04434365

NCT07359209

NCT04479202

NCT03378934

NCT06782646

NCT02082756

NCT04698330

NCT05647915

NCT02548832

NCT05596214

NCT05014334

NCT02861261

Known as BBR “Our previous clinical trial demonstrated that berberine (BBR) hydrochloride might reduce the recurrence and canceration of colorectal adenoma (CRA).” PMID 37553874 Aug 2023
8

“Berberine (BBR) hydrochloride is an isoquinoline alkaloid (chemical formula: C20H18NO4) extracted from traditional Chinese herb Coptis chinensis.” NCT04790942

“Measures altering gut microbiota like oral intake of probiotics or berberine (BBR), a bacteriostatic agent, merit metabolic homoeostasis.” PMID 33024120 Oct 2020

“Berberine (BBR), a small alkaloid isolated from medicinal plants, has antidiabetic, anti-inflammatory, and antibacterial effects.” PMID 35784546 Jun 2022

“Berberine (BBR), an isoquinoline alkaloid derived from plants, is widely used as a nonprescription drug to treat diarrhea.” NCT03909763

“Here, we report the effects of its main active component, berberine (BBR), on stimulating insulin secretion.” PMID 34556670 Sep 2021

“a compound called berberine (BBR) can safely and effectively improve these negative symptoms in SZ.” NCT07356765

“Berberine (BBR) is the main active ingredient of the ancient Chinese herb medicine Coptis.” NCT05947370

“a botanic compound berberine (BBR) on NAFLD” PMID 26252777 Aug 2015

Known as Berbericine ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Berberin ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Berberine Chloride ClinicalTrials.gov intervention name — accepted as the source's own label NCT02365480
Known as berberine hydrochloride berberine hydrochloride tablets (0.1g\*100 tablets/bottle, Shenyang First Pharmaceutical Co., Ltd., Northeast Pharmaceutical Group)” NCT07180563
7

“Patients in the berberine group received berberine hydrochloride tablets (100 mg/tablet), three tablets three times daily.” NCT07359209

Berberine hydrochloride is a conventional component in Chinese medicine.” NCT02226185

“Drug: Berberine Hydrochloride group” NCT03330184

NCT03281096

NCT03333265

NCT04790942

NCT07519681

Known as Berberine hydrochloride tablet ("Sine Tianping") Berberine hydrochloride tablet ("Sine Tianping")NCT03281096
Known as BERBERINE SULFATE ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Berberine sulfate (2:1) ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Berberine sulfate anhydrous ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Berberine sulphate ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Berberinum ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Berberone ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Erben ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as GNF-Pf-4545 ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Majarine ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Neutral berberine sulfate ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as NSC-163088 ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as NSC-5355 ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as NSC-646666 ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Rhizoma Coptidis “The oral Chinese herbal formula will be composed of 18 herbs:Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Rhizoma diosscoreae, Poria, Semen Cuscutae,...” NCT02194946
Known as Thalsine ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Umbellatin ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Known as Umbellatine ChEMBL registry synonym — accepted as the source's own label CHEMBL295124
Action Inhibit “BBR might inhibit V. parvula and further weaken the immunomodulatory effect of B cells induced by V. parvula, thereby blocking the development of colorectal tumors.” PMID 37553874 Aug 2023